BMS settles US off-label marketing case for $19.5mBMS illegally promoted schizophrenia drug, says attorney general Share XBMS settles US off-label marketing case for $19.5mhttps://pharmaphorum.com/news/bms-settles-off-label-marketing-case-19-5m/